Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

ABBOTINDIA's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 0.00000
forwardPE 38.73838
debtToEquity 4.64600
earningsGrowth 0.11500
revenueGrowth 0.11600
grossMargins 0.45281
operatingMargins 0.24512
trailingEps 684.45000
forwardEps 0.00000

With earnings and revenue growth in positive territory, Abbott India Limited is projected to expand its business. This strong financial performance suggests the company will continue to grow, as increased profitability and sales drive future success.
ABBOTINDIA's positive gross and operating margins suggest strong profitability. These margins reflect effective cost management and revenue generation, indicating that the company is efficiently managing its operations and maintaining financial health.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

ABBOTINDIA's price has often been near the lower end of the projected range. This ongoing trend suggests that investor confidence might be waning, and the stock could face challenges in gaining upward momentum.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


Analysts' recent buy bias toward ABBOTINDIA suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see ABBOTINDIA as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.